0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Adult-Onset Neurodegeneration With Brain Iron Accumulation and Cortical α-Synuclein and Tau Pathology: A Distinct Clinicopathological Entity FREE

George K. Tofaris, PhD, MRCP; Tamas Revesz, MD, FRCPath; Thomas S. Jacques, PhD, MRCP, MRCPath; Savvas Papacostas, MD; Jeremy Chataway, MA, PhD, MRCP
[+] Author Affiliations

Author Affiliations: Department of Clinical Neurology, National Hospital for Neurology and Neurosurgery (Drs Tofaris and Chataway), Division of Neuropathology, Institute of Neurology (Dr Revesz), and Neural Development Unit and Department of Histopathology, Institute of Child Health and Great Ormond Street Hospital (Dr Jacques), London, England; and Institute of Neurology and Genetics, Nicosia, Cyprus (Dr Papacostas).


Arch Neurol. 2007;64(2):280-282. doi:10.1001/archneur.64.2.280.
Text Size: A A A
Published online

ABSTRACT

Background  Neurodegeneration with brain iron accumulation is a rare neurodegenerative disorder characterized by iron deposition in the basal ganglia and neuroaxonal dystrophy. Familial cases with mutations in the pantothenate kinase gene are associated with a specific phenotype. In contrast, sporadic cases are heterogeneous in their clinical presentation.

Objective  To describe an atypical case of sporadic late-onset neurodegeneration with brain iron accumulation.

Design, Setting, and Patient  Case report of a patient who presented with psychiatric features at age 22 years followed by progressive gait disturbance, extrapyramidal symptoms, epilepsy, and corticospinal tract involvement.

Results  Magnetic resonance imaging showed iron deposition in the globus pallidus and substantia nigra. Cortical biopsy revealed Lewy bodies with predominant α-synuclein and less extensive tau-positive neurites.

Conclusions  Our findings in association with previously reported cases suggest that cortical neuritic and Lewy body pathology is a feature of atypical neurodegeneration with brain iron accumulation, clinically characterized by adult onset and psychiatric symptoms. These observations raise the possibility that these cases of atypical neurodegeneration with brain iron accumulation represent a distinct clinicopathological syndrome and suggest a molecular link between iron deposition and α-synuclein accumulation.

Figures in this Article

Neurodegeneration with brain iron accumulation (NBIA), previously known as Hallervorden-Spatz disease, is a rare autosomal recessive or sporadic neurodegenerative disorder. The diagnosis of NBIA is based on clinical criteria and has been classified by the onset of symptoms into the following: (1) early-onset childhood type (diagnosis earlier than age 10 years), which includes both rapidly and slowly progressive types; (2) late-onset slowly progressive type with presentation between ages 10 and 18 years; and (3) adult-onset slowly progressive type.1 Genetic studies have identified mutations in the pantothenate kinase 2 (PANK2) gene in familial cases of NBIA that have specific clinical features (termed pantothenate kinase–associated neurodegeneration2). In contrast, sporadic cases of NBIA have a heterogeneous clinical presentation and therefore may represent a distinct syndrome.

REPORT OF A CASE

A 27-year-old woman had normal motor and intellectual development and no family history of neurological disease. At age 22 years, she developed mood changes such as indifference and loss of impetus. Two days after an emergency appendectomy that was uneventful, she became irritable and aggressive. This was associated with transient auditory hallucinations. She was initially treated with haloperidol but developed extrapyramidal adverse effects. Within 9 months, she became mute and required electroconvulsive therapy, which lifted her mood transiently. Her extrapyramidal syndrome also improved on switching to clozapine. However, by age 24 years, her gait became shuffling and she experienced falls. She became bradykinetic and developed micrographia. She began receiving levodopa but within 7 months developed drug-induced orofacial and limb dyskinesias, which responded to treatment. At age 26 years, she had a single generalized convulsion. Anticonvulsive therapy was initiated and was effective. A progressive decline in her language ability had been noted since age 24 years, and at about the time of her seizure, she was unable to engage in conversation and could only say occasional words. She is currently dependent for most activities of daily living. General examination was unremarkable apart from hypomimia and emaciation. Higher mental functions were severely impaired on verbal and nonverbal tests of reasoning. She had weak visual perceptual and visuospatial skills, comprehension difficulties, dyscalculia, and impaired memory skills. Pursuit eye movements were jerky and vertical saccades were slow. There was marked dystonic posturing in both arms and legs. The reflexes were brisk and the plantar responses were spontaneously extensor. Biochemical and hematological test results were normal. There were no acanthocytes in her peripheral blood. Cerebrospinal fluid examination results were unremarkable. Genetic test results were negative for Huntington disease, spinocerebellar ataxia 1, 2, 3, 6, 7, 12, and 14, dentorubropallidolysian atrophy, and PANK2, DYT1, ferritin light-chain gene, and α-synuclein gene mutations. Electroencephalography showed normal activity. Magnetic resonance imaging of her brain at age 27 years showed severe cerebral atrophy with a frontotemporal predominance. The T2-weighted images demonstrated low signal intensity, indicative of abnormal iron deposition in the globus pallidus, cerebral peduncles, and substantia nigra, although no “eye of the tiger” sign was seen (Figure, A). A computed tomographic scan excluded basal ganglia calcification. Muscle biopsy showed mild nonspecific myopathic features, and results of a muscle mitochondrial assay for respiratory chain function were normal. Results of liver biopsy for copper deposition were negative. Frontal cortical biopsy was also performed.

Place holder to copy figure label and caption
Figure.

Imaging studies. A, The T2-weighted magnetic resonance images demonstrated low signal intensity consistent with abnormal iron deposition in the substantia nigra and the globus pallidus. B, Hematoxylin-eosin staining revealed numerous eosinophilic inclusions (arrow) resembling Lewy bodies in the cortex. C, Anti–α-synuclein staining revealed Lewy bodies (arrows) and extensive Lewy neurites (arrowheads). D, Tau-positive neurites (arrows) were detected throughout the neocortex but spared the white matter. E, An occasional neurite was positive for both tau and α-synuclein (arrow) (red indicates α-synuclein; green, tau).

Graphic Jump Location

Microscopical examination of the sections revealed gliosis affecting the cortex and white matter. Numerous cortical Lewy bodies (Figure, B), which were positive for α-synuclein (Figure, C), were seen. In addition, anti–α-synuclein staining revealed severe Lewy neurite pathology throughout the thickness of the cortex (Figure, C). Sparse α-synuclein neurites were also seen within the white matter. Immunohistochemistry for tau revealed neuritic pathology throughout the neocortex but sparing of the white matter (Figure, D). Neurofibrillary tangles were not seen. The appearance of these neurites was similar to those stained with α-synuclein antibodies. Double immunofluorescence staining showed that the 2 proteins very rarely colocalized within the same aggregates (Figure, E). No β-amyloid–positive pathology was seen. No glial inclusions (eg, coiled bodies or tufted astrocytes) were identified, and there was no morphological evidence of neuronal or glial cell apoptosis. No axonal swellings were identified; however, deep gray structures were not available for examination.

COMMENT

It is now well recognized that the diagnosis of NBIA applies to a spectrum of disorders.1 Following the identification of PANK2 mutations in familial NBIA, it has been shown that patients with deletion mutations have classic disease and present before age 6 years, commonly with gait or postural difficulties, early extrapyramidal symptoms, and involvement of the corticospinal tracts, whereas those with sporadic disease or some with point mutations have atypical late presentation with more frequent corticospinal tract involvement and prominent psychiatric symptoms with cognitive decline. There is also a striking correlation between the presence of PANK2 mutations and the eye of the tiger sign.2 The findings described earlier are consistent with the observations in our patient, who had adult-onset disease with psychiatric presentation, iron accumulation in the basal ganglia without the eye of the tiger sign, and no mutation in the PANK2 gene.

Although a distinct phenotypic classification seems to emerge based on genetic screening, the pathological substrate for the clinical heterogeneity in NBIA is poorly understood. Until recently, the most prominent microscopical finding alongside iron deposition, neuronal loss, gliosis, and loss of myelin was the presence of widely disseminated, rounded or oval structures termed spheroids identifiable as swollen axons.1 It has now become apparent that neuropathologically, NBIA belongs to the growing list of α-synucleinopathies based on the identification of α-synuclein–immunoreactive Lewy bodies and Lewy neurites in a number of published cases.37 It is therefore possible that in NBIA, axonal spheroids and dystrophic neurites represent a pathological spectrum signifying a degenerative process affecting the neuronal processes and α-synuclein deposition represents a marker of axonal or dendritic injury. In contrast to α-synuclein pathology, the presence of neurofibrillary tangles is not a prominent feature of this disorder.5 We identified only 6 reports5,711 of NBIA with coexistent α-synuclein and tau pathology. It is noteworthy that in all of the reported cases as in our patient, dual pathology was associated with prominent cognitive decline. Furthermore, NBIA cases with cortical Lewy bodies6,1114 share clinical features with our patient, such as adult-onset and prominent psychiatric features (cognitive decline, mood changes, dysphoria, blunted affect, and auditory hallucinations), which are distinct from classical dementia with Lewy bodies (prominent visual hallucinations and fluctuating cognition and alertness15). The pathological findings described earlier suggest that patients with atypical disease are more likely to develop widespread α-synuclein with or without tau pathology especially in cortical regions, which could explain the prominence of psychiatric symptoms in this group.

In this respect, adult onset and protracted course could represent the clinical corollary to a slow retrograde neurodegenerative process with the axonal terminals being the anatomical substrate of the primary insult. When iron accumulates in excess, as in NBIA, it generates reactive free radicals and damages lipid membranes. Oxidation of α-synuclein, a presynaptic protein that binds to lipid membranes, induces conformational changes and aggregation of the protein.16 It is therefore possible that cortical projections to areas where iron accumulates are damaged by oxidative stress, inducing aggregation of α-synuclein and neuritic pathology. With time, this may disrupt axonal transport leading to accumulation of α-synuclein and other proteins such as tau (an axonal protein involved in stabilization of microtubules) proximally, formation of perikaryal aggregates, and cellular demise. Our findings of α-synuclein and tau neuritic deposits with minimal colocalization may help to explain dual α-synuclein and tau pathology, which is increasingly being recognized in a number of other neurodegenerative diseases.

In summary, our findings in association with those of previously reported cases suggest that cortical involvement is a feature of atypical NBIA characterized clinically by psychiatric features and pathologically by extensive neuroaxonal dystrophy. These observations may help in understanding the neurodegenerative process and raise the possibility that atypical NBIA represents a distinct clinicopathological syndrome. Further pathological and molecular studies are necessary to characterize this syndrome, which in turn may help in understanding the pathogenesis of other α-synucleinopathies.

ARTICLE INFORMATION

Correspondence: George K. Tofaris, PhD, MRCP, Department of Clinical Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, England (gt223@doctors.net.uk).

Accepted for Publication: April 3, 2006.

Author Contributions:Study concept and design: Tofaris. Acquisition of data: Tofaris, Revesz, Jacques, Papacostas, and Chataway. Analysis and interpretation of data: Tofaris, Revesz, Jacques, and Chataway. Drafting of the manuscript: Tofaris. Critical revision of the manuscript for important intellectual content: Tofaris and Chataway. Administrative, technical, and material support: Tofaris, Jacques, and Papacostas. Study supervision: Revesz and Chataway.

Financial Disclosure: None reported.

Acknowledgment: We would like to thank Maria Grazia Spillantini, PhD, for sequencing the α-synuclein gene.

REFERENCES

Swaiman  KF Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;481285- 1293
PubMed Link to Article
Hayflick  SJWestaway  SKLevinson  B  et al.  Genetic, clinical and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;34833- 40
PubMed Link to Article
Arawaka  SSaito  YMurayama  SMori  H Lewy body in neurodegeneration with brain iron accumulation 1 is immunoreactive for α-synuclein. Neurology 1998;51887- 889
PubMed Link to Article
Newell  KLBoyer  PGomez-Tortosa  E  et al.  α-Synuclein immunoreactivity is present in axonal swellings of neuroaxonal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol 1999;581263- 1268
PubMed Link to Article
Wakabayashi  KFukushima  TKoide  R  et al.  Juvenile-onset generalised neuroaxonal dystrophy with diffuse neurofibrillary and Lewy body pathology. Acta Neuropathol (Berl) 2000;99331- 336
PubMed Link to Article
Neumann  MAdler  SSchluter  OKremmer  EBenecke  RKretzschmar  HA α-Synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol (Berl) 2000;100568- 574
PubMed Link to Article
Saito  YKawai  MInoue  K  et al.  Widespread expression of α-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course. J Neurol Sci 2000;17748- 59
PubMed Link to Article
Eidelberg  DSotrel  AJoachim  C  et al.  Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. Brain 1987;110993- 1013
PubMed Link to Article
Fuse  SInoue  KIwata  MMannen  TToyokura  Y An autopsy case of Hallervorden-Spatz disease with protracted course of about 30 years [in Japanese]. Rinsho Shinkeigaku 1987;27155- 167
Gaytan-Garcia  SKaufmann  JCEYoung  GB Adult-onset Hallervorden-Spatz syndrome or Seitelberger's disease with late onset. Clin Neuropathol 1990;9136- 142
PubMed
Hayashi  SAkasaki  YMorimura  YTakauchi  SSato  MMiyoshi  K An autopsy case of late infantile and juvenile neuroaxonal dystrophy with diffuse Lewy bodies and neurofibrillary tangles. Clin Neuropathol 1992;111- 5
PubMed
Williamson  KSima  AAFCurry  BLudwin  SK Neuroaxonal dystrophy in young adults. Ann Neurol 1982;11335- 343
PubMed Link to Article
Sugiyama  HHainfellner  JASchmid-Siegel  BBudka  H Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult. Clin Neuropathol 1993;12147- 152
PubMed
Dymecki  JBertrand  ETomankiewicz  ZSzuniewicz  H Hallervorden-Spatz disease in an adult patient. Folia Neuropathol 1999;37235- 238
PubMed
McKeith  IGGalasko  DKosaka  K  et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Neurology 1996;471113- 1124
PubMed Link to Article
Norris  EHGiasson  BIIschiropoulos  HLee  VM Effects of oxidative and nitrative challenges on α-synuclein fibrillogenesis involves distinct mechanisms of protein modifications. J Biol Chem 2003;27827230- 27240
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure.

Imaging studies. A, The T2-weighted magnetic resonance images demonstrated low signal intensity consistent with abnormal iron deposition in the substantia nigra and the globus pallidus. B, Hematoxylin-eosin staining revealed numerous eosinophilic inclusions (arrow) resembling Lewy bodies in the cortex. C, Anti–α-synuclein staining revealed Lewy bodies (arrows) and extensive Lewy neurites (arrowheads). D, Tau-positive neurites (arrows) were detected throughout the neocortex but spared the white matter. E, An occasional neurite was positive for both tau and α-synuclein (arrow) (red indicates α-synuclein; green, tau).

Graphic Jump Location

Tables

References

Swaiman  KF Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;481285- 1293
PubMed Link to Article
Hayflick  SJWestaway  SKLevinson  B  et al.  Genetic, clinical and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;34833- 40
PubMed Link to Article
Arawaka  SSaito  YMurayama  SMori  H Lewy body in neurodegeneration with brain iron accumulation 1 is immunoreactive for α-synuclein. Neurology 1998;51887- 889
PubMed Link to Article
Newell  KLBoyer  PGomez-Tortosa  E  et al.  α-Synuclein immunoreactivity is present in axonal swellings of neuroaxonal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol 1999;581263- 1268
PubMed Link to Article
Wakabayashi  KFukushima  TKoide  R  et al.  Juvenile-onset generalised neuroaxonal dystrophy with diffuse neurofibrillary and Lewy body pathology. Acta Neuropathol (Berl) 2000;99331- 336
PubMed Link to Article
Neumann  MAdler  SSchluter  OKremmer  EBenecke  RKretzschmar  HA α-Synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol (Berl) 2000;100568- 574
PubMed Link to Article
Saito  YKawai  MInoue  K  et al.  Widespread expression of α-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course. J Neurol Sci 2000;17748- 59
PubMed Link to Article
Eidelberg  DSotrel  AJoachim  C  et al.  Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. Brain 1987;110993- 1013
PubMed Link to Article
Fuse  SInoue  KIwata  MMannen  TToyokura  Y An autopsy case of Hallervorden-Spatz disease with protracted course of about 30 years [in Japanese]. Rinsho Shinkeigaku 1987;27155- 167
Gaytan-Garcia  SKaufmann  JCEYoung  GB Adult-onset Hallervorden-Spatz syndrome or Seitelberger's disease with late onset. Clin Neuropathol 1990;9136- 142
PubMed
Hayashi  SAkasaki  YMorimura  YTakauchi  SSato  MMiyoshi  K An autopsy case of late infantile and juvenile neuroaxonal dystrophy with diffuse Lewy bodies and neurofibrillary tangles. Clin Neuropathol 1992;111- 5
PubMed
Williamson  KSima  AAFCurry  BLudwin  SK Neuroaxonal dystrophy in young adults. Ann Neurol 1982;11335- 343
PubMed Link to Article
Sugiyama  HHainfellner  JASchmid-Siegel  BBudka  H Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult. Clin Neuropathol 1993;12147- 152
PubMed
Dymecki  JBertrand  ETomankiewicz  ZSzuniewicz  H Hallervorden-Spatz disease in an adult patient. Folia Neuropathol 1999;37235- 238
PubMed
McKeith  IGGalasko  DKosaka  K  et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Neurology 1996;471113- 1124
PubMed Link to Article
Norris  EHGiasson  BIIschiropoulos  HLee  VM Effects of oxidative and nitrative challenges on α-synuclein fibrillogenesis involves distinct mechanisms of protein modifications. J Biol Chem 2003;27827230- 27240
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,170 Views
20 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
×